294 related articles for article (PubMed ID: 25092681)
1. Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Akpek M; Sahin O; Sarli B; Baktir AO; Saglam H; Urkmez S; Ergin A; Oguzhan A; Arinc H; Kaya MG
Angiology; 2015 Jul; 66(6):560-7. PubMed ID: 25092681
[TBL] [Abstract][Full Text] [Related]
2. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R
JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study.
Zhu TQ; Zhang Q; Qiu JP; Jin HG; Lu L; Shen J; Zhao LP; Zhang RY; Hu J; Yang ZK; Shen WF
Int J Cardiol; 2013 May; 165(3):437-43. PubMed ID: 21940058
[TBL] [Abstract][Full Text] [Related]
5. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
[TBL] [Abstract][Full Text] [Related]
6. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Kırma C; Erkol A; Pala S; Oduncu V; Dündar C; İzgi A; Tigen K; Gibson CM
Catheter Cardiovasc Interv; 2012 Jan; 79(1):59-67. PubMed ID: 21523892
[TBL] [Abstract][Full Text] [Related]
8. Effects of upstream administration of tirofiban before percutaneous coronary intervention on spontaneous reperfusion and clinical outcomes in acute ST-segment elevation myocardial infarction.
Zhu J; Zhang T; Xie Q; Zhang J
Angiology; 2015 Jan; 66(1):70-8. PubMed ID: 24327765
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction.
Celik T; Kaya MG; Akpek M; Gunebakmaz O; Balta S; Sarli B; Duran M; Demirkol S; Uysal OK; Oguzhan A; Gibson CM
Angiology; 2015 Feb; 66(2):155-62. PubMed ID: 24301422
[TBL] [Abstract][Full Text] [Related]
10. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.
Fu XH; Hao QQ; Jia XW; Fan WZ; Gu XS; Wu WL; Hao GZ; Li SQ; Jiang YF; Geng W
Chin Med J (Engl); 2008 Mar; 121(6):522-7. PubMed ID: 18364139
[TBL] [Abstract][Full Text] [Related]
11. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy comparison of combined intracoronary administration of high-dose adenosine and tirofiban versus intracoronary tirofiban during primary percutaneous coronary intervention in patients with acute myocardial infarction].
Tong ZC; Li Q; Chen M; Miao GB; Wei Y; Li FO; Zhao H; Zhang JJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Oct; 41(10):839-44. PubMed ID: 24377889
[TBL] [Abstract][Full Text] [Related]
13. Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction.
Faruk Akturk I; Arif Yalcin A; Biyik I; Sarikamis C; Turhan Caglar N; Erturk M; Celik O; Uzun F; Murat Caglar I; Oner E
Minerva Cardioangiol; 2014 Oct; 62(5):389-97. PubMed ID: 24699550
[TBL] [Abstract][Full Text] [Related]
14. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
[TBL] [Abstract][Full Text] [Related]
15. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes.
Yip HK; Wu CJ; Chang HW; Hsieh YK; Fang CY; Chen SM; Chen MC
Chest; 2003 Sep; 124(3):962-8. PubMed ID: 12970024
[TBL] [Abstract][Full Text] [Related]
16. Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.
Peng Y; Fu X; Li W; Geng W; Xing K; Ru L; Sun J; Zhao Y
Coron Artery Dis; 2014 Dec; 25(8):645-52. PubMed ID: 25230304
[TBL] [Abstract][Full Text] [Related]
17. In-Lab Upfront Use of Tirofiban May Reduce the Occurrence of No-Reflow During Primary Percutaneous Coronary Intervention. A Pilot Randomized Study.
Lago IM; Novaes GC; Badran AV; Pavão RB; Barbosa R; Figueiredo GL; Lima MO; Haddad JL; Schmidt A; Marin JA
Arq Bras Cardiol; 2016 Nov; 107(5):403-410. PubMed ID: 27982267
[TBL] [Abstract][Full Text] [Related]
18. Short-term effect of upstream administration in comparison to deferred injection of tirofiban on patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Jia Z; Guo M; Zhang YQ; Liang HQ; Song Y
J Interv Cardiol; 2013 Aug; 26(4):332-9. PubMed ID: 23844823
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: results of the ICTUS-AMI trial.
Zhu TQ; Zhang Q; Ding FH; Qiu JP; Jin HG; Jiang L; Lu L; Zhang RY; Hu J; Yang ZK; Shen Y; Shen WF
Chin Med J (Engl); 2013 Aug; 126(16):3079-86. PubMed ID: 23981616
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of intracoronary versus intravenous high-dose bolus administration of tirofiban in diabetic patients undergoing primary percutaneous coronary intervention.
Ghonim AA; Mostafa A; Emara A; Algazzar AS; Qutub MA
Cardiovasc J Afr; 2019 Sep/Oct 23; 30(5):285-289. PubMed ID: 31194213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
